Lv31
350 积分 2025-04-09 加入
International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials
4天前
已完结
An up-to-date review of emerging biologic therapies for hypercholesterolemia
30天前
已完结
Olezarsen and Post-prandial Triglyceride Levels
1个月前
已完结
Global burden and characterization of hypertriglyceridemia-induced acute pancreatitis: results from a systematic review and a multi-center cohort study
1个月前
已完结
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia
2个月前
已完结
Novel agents for treating severe hypertriglyceridemia
2个月前
已完结
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
3个月前
已完结
Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia
3个月前
已完结
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
3个月前
已完结
Plasma reduction of apolipoprotein C-III with olezarsen leads to significant reductions in postprandial triglyceride levels: Results from a randomized trial
3个月前
已完结
皖公网安备34019202002308
